{"id":"W4414066483","doi":"10.3390/cancers17172924","title":"A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Children's Hospital","funders":"National Cancer Institute; Amgen","keywords":"Etoposide; Refractory (planetary science); Carfilzomib; Cyclophosphamide; Solid tumor; Leukemia; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002484105,0.001533601,0.001999169,0.0006245069,0.0005542974,0.0008121313,0.001147078,0.001102113,0.003290314],"category_scores_gemma":[0.000905384,0.0006611774,0.001457503,0.0005606234,0.0008832138,0.0007278738,0.000451227,0.002764021,0.0008778718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008964002,"about_ca_system_score_gemma":0.002773956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001481148,"about_ca_topic_score_gemma":0.002803587,"domain_scores_codex":[0.9992145,0.0003578198,0.00005269186,0.0001201621,0.0000865876,0.0001681743],"domain_scores_gemma":[0.9987893,0.0001176067,0.0002336685,0.0001099152,0.0000748062,0.0006747432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6417098,0.1848403,0.01052119,0.001027024,0.001431154,0.0005102225,0.0004000635,0.002040069,0.06618695,0.0003221512,0.00324272,0.08776841],"study_design_scores_gemma":[0.4616169,0.5215628,0.0102726,0.0000271153,0.0003074986,0.0003205711,0.0000386907,0.0005503515,0.003095168,0.00009795785,0.002093226,0.00001707491],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900637,0.001774715,0.0004854567,0.000333055,0.00009895953,0.005283152,0.0007176375,0.00006121398,0.001182144],"genre_scores_gemma":[0.9831403,0.00236827,0.002853378,0.0007540452,0.0002196128,0.006007257,0.002573762,0.00002354346,0.002059748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003290314,"threshold_uncertainty_score":0.01313734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00761967445750081,"score_gpt":0.2682989760022261,"score_spread":0.2606793015447253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}